Mikhail Kesler, MD

Specializations

  • Nuclear Medicine
  • Diagnostic Radiology

 Education

  • 2013 — 2018, Nuclear medicine residency, Tel-Aviv Sourasky Medical Center. Tel-Aviv, Israel.
  • 2011–2012, Body Imaging Fellowship, Rambam Health Care Campus. Haifa, Israel.
  • 2009–2011, Diagnostic Radiology Residency, I.M. Sechenov Moscow Medical Academy. Moscow, Russia.
  • 2002-2008, Omsk State Medical Academy, Faculty of pediatrics, MD. Omsk, Russia.

Сurrent position

  • Attending Nuclear medicine specialist and Director of clinical services, Tel Aviv Sourasky Medical Center (link).
  • Lecturer in Diagnostic Imaging, Tel Aviv University, Sackler Faculty of Medicine (link).

Research & Publications

Original research

  • Kesler M, Cohen D, Levine C, Sarid D, Keizman D, Yossepowitch O, Even-Sapir E. Staging Prostate Cancer with 68Ga-PSMA-11 PET/CT in the Elderly: Is Preimaging Biopsy Imperative? J Nucl Med. 2023 (link
  • Cohen D, Kesler M, Muchnik-Kurash M, Even-Sapir E, Levine C. A lesson in humility: the added values of PET-MRI over PET-CT in detecting malignant hepatic lesions. Eur J Nucl Med Mol Imaging, 2023. (link)
  • Cohen D, Hazut Krauthammer S, Fahoum I, Kesler M, Even-Sapir E. PET radiotracers for whole-body in vivo molecular imaging of prostatic neuroendocrine malignancies. Eur Radiol. 2023 (link)
  • Levine C, Talmon Y, Kesler M, Kuten J and Even-Sapir E. Head-To-Head Comparison of Lesion Detection and PET Metrics on 18F-FDG PET/CT and PET/MR in Hepatic Metastases. J Clin Med Img. 2022 (link)
  • Cohen D, Perry C, Hazut-Krauthammer S, Kesler M, Herishanu Y, Luttwak E, Even-Sapir E, Avivi I. Is There a Role for [18F]FDG PET-CT in Staging MALT Lymphoma? Cancers. 2022 (link)
  • Kesler M, Kerzhner K, Druckmann I, Kuten J, Levine C, Sarid D, Keizman D, Yossepowitch O, Even-Sapir E. Staging 68 Ga-PSMA PET/CT in 963 consecutive patients with newly diagnosed prostate cancer: incidence and characterization of skeletal involvement. Eur J Nucl Med Mol Imaging. 2021 (link
  • Kesler M, Druckmann I, Levine C, Kuten J, Yossepowitch O, Even-Sapir E. 68Ga-PSMA-11 PET/CT Follow-Up of Patients with Prostate Cancer with Bone Metastases Who Had Reduced Bone Density after Androgen Deprivation Therapy. Diagnostics (Basel). 2021 (link)
  • Kesler M, Levine C, Hershkovitz D, Mishani E, Menachem Y, Lerman H, Zohar Y, Shibolet O, Even-Sapir E. 68Ga-PSMA is a novel PET-CT tracer for imaging of hepatocellular carcinoma: A prospective pilot study. J Nucl Med. 2018 (link).
  • Herishanu Y, Lerman H, Perry C, Joffe E, Sarid N, Amit O, Avivi I, Kesler M, Ben-Ezra J, Even-Sapir E, Perry C. The value of PET-CT in detecting bone marrow involvement in patients with follicular lymphoma. Medicine (Baltimore). 2016 (link
  • Koulikov V, Lerman H, Kesler M, Even-Sapir E. 99mTc-MDP bone scintigraphy of the hand: comparing the use of novel cadmium zinc telluride (CZT) and routine NaI(Tl) detectors. EJNMMI Res. 2015 (link)

Review

  • Kuten J, Kesler M, Even-Sapir E. The role of PSMA PET/CT in imaging prostate cancer. Harefuah. 2021 (link)
  • Khamis K, Giladi N, Levine C, Kesler M, Kuten J, Lerman H, Even-Sapir E. The Added Value of 18F-FDOPA PET/CT in the Work-Up of Patients with Movement Disorders. Neurographics, 2019 (link)
  • Kesler M. Modern methods of nuclear medicine in complex diagnostics of breast cancer. Review. REJR, 2012 (link)